These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20335443)

  • 1. The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.
    Mangos S; Lam PY; Zhao A; Liu Y; Mudumana S; Vasilyev A; Liu A; Drummond IA
    Dis Model Mech; 2010; 3(5-6):354-65. PubMed ID: 20335443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystins, focal adhesions and extracellular matrix interactions.
    Drummond IA
    Biochim Biophys Acta; 2011 Oct; 1812(10):1322-6. PubMed ID: 21396443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd2).
    Khonsari RH; Ohazama A; Raouf R; Kawasaki M; Kawasaki K; Porntaveetus T; Ghafoor S; Hammond P; Suttie M; Odri GA; Sandford RN; Wood JN; Sharpe PT
    Hum Mol Genet; 2013 May; 22(9):1873-85. PubMed ID: 23390131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.
    Chang MY; Ma TL; Hung CC; Tian YC; Chen YC; Yang CW; Cheng YC
    Sci Rep; 2017 Aug; 7(1):7161. PubMed ID: 28769124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the secretory pathway rescues zebrafish polycystic kidney disease pathology.
    Le Corre S; Eyre D; Drummond IA
    J Am Soc Nephrol; 2014 Aug; 25(8):1749-59. PubMed ID: 24627348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 7. Channel Function of Polycystin-2 in the Endoplasmic Reticulum Protects against Autosomal Dominant Polycystic Kidney Disease.
    Padhy B; Xie J; Wang R; Lin F; Huang CL
    J Am Soc Nephrol; 2022 Aug; 33(8):1501-1516. PubMed ID: 35835458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
    Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
    BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
    Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
    J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
    Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
    J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pkd1 is required for male reproductive tract development.
    Nie X; Arend LJ
    Mech Dev; 2013; 130(11-12):567-76. PubMed ID: 23933588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high throughput zebrafish chemical screen reveals ALK5 and non-canonical androgen signalling as modulators of the pkd2
    Metzner A; Griffiths JD; Streets AJ; Markham E; Philippou T; Van Eeden FJM; Ong ACM
    Sci Rep; 2020 Jan; 10(1):72. PubMed ID: 31919453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PKD2 (polycystin 2) mutations with left-right laterality defects.
    Bataille S; Demoulin N; Devuyst O; Audrézet MP; Dahan K; Godin M; Fontès M; Pirson Y; Burtey S
    Am J Kidney Dis; 2011 Sep; 58(3):456-60. PubMed ID: 21719175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
    Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
    J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.